Table 3. Patient characteristics.
| Study | Study arm | Age | Male | EuroScore | DM | COPD | Cr level | Cr >2 | PVD | CVD | CAD | Prior cardiac surgery | NYHA III/IV | EF <50% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Blackman (9) | TF | 81.1±7.6 | 376 | 19.5±14.2 | 158 | 185 | 115.8±60.0 mol/L | NR | 136 | 103 | 299 | 230 | NR | 259 |
| TAx | 82.0±6.5 | 64 | 25.9±16.9 | 23 | 26 | 127.4±82.2 mol/L | NR | 52 | 17 | 48 | 33 | NR | 41 | |
| Eltchaninoff (18) | TF | 82.5±5.9 | 32 | 24.7 ± 11.2 | 22 | NR | NR | NR | NR | 8 | 28 | NR | 53 | NR |
| TAx | 75.5±11.0 | 6 | 24.6 ±14.5 | 1 | NR | NR | NR | NR | 1 | 6 | NR | 6 | NR | |
| Gleason (4) | TF | 80.2±9.7 | 119 | 19.4±15.0 | 87 | 138 | NR | 12 | 117 | 21 | 169 | 56 | 181 | NR |
| TAx | 80.8±8.1 | 129 | 20.7±14.3 | 87 | 134 | NR | 10 | 122 | 20 | 165 | 68 | 179 | NR | |
| Muensterer (5) | TF | 80.2±7.0 | 135 | 19.2±12.8 | NR | 61 | 1.19±0.54 mg/dL | NR | 42 | 33 | 157 | 49 | 287 | 115 |
| TAx | 79.5±8.5 | 23 | 21.5±12.2 | NR | 10 | 1.22±0.50 mg/dL | NR | 17 | 9 | 24 | 6 | 40 | 22 | |
| Petronio (6) | TF | 83* | 81 | 23.3* | NR | NR | NR | 12 | 29 | 13 | 69 | NR | 96 | NR |
| TAx | 83* | 86 | 23.7* | NR | NR | NR | 19 | 120 | 18 | 83 | NR | 102 | NR |
Values are n, mean ± SD, or median (*). CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; Cr, creatinine; CVD, cerebrovascular disease; DM, diabetes mellitus; EF, ejection fraction; NR, not reported; NYHA, New York Heart Association; PVD, peripheral vascular disease; TAx, transaxillary; TF, transfemoral.